Presence of a Ground-Glass Opacity Component Is the True Prognostic Determinant in Clinical Stage I NSCLC

CONCLUSIONS: These results suggest that presence of GGO is the true prognostic determinant of stage I NSCLC, irrespective of the size of the solid component. Our novel T descriptor classification system could more accurately predict prognoses of clinical stage I NSCLC cases.PMID:35574192 | PMC:PMC9097453 | DOI:10.1016/j.jtocrr.2022.100321

Source: Clinical Lung Cancer - May 16, 2022 Category: Cancer & Oncology Authors: Akira Hamada Kenichi Suda Toshio Fujino Masaya Nishino Shuta Ohara Takamasa Koga Takanobu Kabasawa Masato Chiba Masaki Shimoji Makoto Endoh Toshiki Takemoto Junichi Soh Naoki Yanagawa Satoshi Shiono Tetsuya Mitsudomi Source Type: research